HYALURONATE\TREHALOSE: 20 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
20
Total FAERS Reports
0
Deaths Reported
12
Hospitalizations
20
As Primary/Secondary Suspect
Active Ingredient: HYALURONATE SODIUM\TREHALOSE ·
First Report: 20151125 · Latest Report: 20200101
What Are the Most Common HYALURONATE\TREHALOSE Side Effects?
#1 Most Reported
Vitamin d deficiency
11 reports (55.0%)
#2 Most Reported
Urinary tract infection
11 reports (55.0%)
#3 Most Reported
Schizophrenia
11 reports (55.0%)
All HYALURONATE\TREHALOSE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Angina pectoris | 11 | 55.0% | 0 | 11 |
| Anxiety disorder | 11 | 55.0% | 0 | 11 |
| Cellulitis | 11 | 55.0% | 0 | 11 |
| Chest pain | 11 | 55.0% | 0 | 11 |
| Chronic obstructive pulmonary disease | 11 | 55.0% | 0 | 11 |
| Delirium | 11 | 55.0% | 0 | 11 |
| Dementia alzheimer's type | 11 | 55.0% | 0 | 11 |
| Dermatitis atopic | 11 | 55.0% | 0 | 11 |
| Dyspepsia | 11 | 55.0% | 0 | 11 |
| Haemorrhoids | 11 | 55.0% | 0 | 11 |
| Hypothyroidism | 11 | 55.0% | 0 | 11 |
| Iron deficiency anaemia | 11 | 55.0% | 0 | 11 |
| Lung neoplasm malignant | 11 | 55.0% | 0 | 11 |
| Pleural effusion | 11 | 55.0% | 0 | 11 |
| Rash | 11 | 55.0% | 0 | 11 |
| Schizophrenia | 11 | 55.0% | 0 | 11 |
| Urinary tract infection | 11 | 55.0% | 0 | 11 |
| Vitamin d deficiency | 11 | 55.0% | 0 | 11 |
| Metastatic neoplasm | 9 | 45.0% | 0 | 9 |
Who Reports HYALURONATE\TREHALOSE Side Effects? Age & Gender Data
Gender: 85.7% female, 14.3% male. Average age: 65.6 years. Most reports from: GB. View detailed demographics →
Is HYALURONATE\TREHALOSE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 11 | 0 | 11 |
| 2019 | 4 | 0 | 0 |
| 2020 | 2 | 0 | 0 |
What Is HYALURONATE\TREHALOSE Used For?
| Indication | Reports |
|---|---|
| Dry eye | 14 |
Official FDA Label for HYALURONATE\TREHALOSE
Official prescribing information from the FDA-approved drug label.